Terumo (OTCMKTS:TRUMY) Sets New 1-Year High – Still a Buy?

Terumo Co. (OTCMKTS:TRUMYGet Free Report) hit a new 52-week high during mid-day trading on Wednesday . The company traded as high as $20.95 and last traded at $20.33, with a volume of 101684 shares traded. The stock had previously closed at $20.12.

Terumo Stock Performance

The company’s 50-day moving average price is $19.47 and its two-hundred day moving average price is $18.17. The company has a market capitalization of $30.31 billion, a price-to-earnings ratio of 42.80 and a beta of 0.64. The company has a debt-to-equity ratio of 0.11, a current ratio of 2.98 and a quick ratio of 1.72.

Terumo Company Profile

(Get Free Report)

Terumo Corporation engages in the manufacture and sale of medical products and equipment in Japan, Europe, China, the United States, Asia, and internationally. The company operates through three segments: Cardiac and Vascular Company, Medical Care Solutions Company, and Blood and Cell Technologies Company.

Featured Stories

Receive News & Ratings for Terumo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Terumo and related companies with MarketBeat.com's FREE daily email newsletter.